The Multifunctional Nature of the MicroRNA/AKT3 Regulatory Axis in Human Cancers

Chun Yang1, Pierre Hardy1,2

  • 1Research Center of CHU Sainte-Justine, University of Montréal, Montreal, QC H3T 1C5, Canada.

Cells
|November 24, 2023
PubMed

Insights

The AKT3 protein, a key regulator in cancer, is controlled by microRNAs (miRNAs). Understanding these miRNA/AKT3 networks can lead to new cancer biomarkers and treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Serine/threonine kinase (AKT) signaling pathways are crucial in cell survival, proliferation, and are frequently dysregulated in cancer, driving tumorigenesis, metastasis, and chemoresistance.
  • Targeting AKT signaling represents a significant therapeutic strategy in oncology.
  • AKT3 (PKBγ), the least studied AKT isoform, plays a critical role in cancer malignancy, with its expression often elevated in various human cancers.

Purpose of the Study:

  • To review the current understanding of AKT3's isoform-specific functions in human cancers.
  • To summarize the roles of dysregulated microRNA (miRNA)/AKT3 interactions in the context of specific human cancers.
  • To highlight the potential of miRNA/AKT3 networks as diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review and synthesis of existing research on AKT3 and its regulatory miRNAs in cancer.
  • Analysis of studies investigating AKT3 overexpression and its oncogenic roles.
  • Examination of identified miRNA regulatory mechanisms targeting AKT3 expression.

Main Results:

  • AKT3 is frequently overexpressed in human cancers, contributing significantly to malignant progression.
  • Numerous oncogenic and tumor suppressor small non-coding RNAs, particularly miRNAs, have been identified as regulators of AKT3 expression.
  • Dysregulation of specific miRNA/AKT3 networks is implicated in the pathogenesis of various cancer types.

Conclusions:

  • AKT3 is a critical mediator of cancer malignancy, with its expression tightly regulated by miRNAs.
  • Understanding the intricate miRNA/AKT3 regulatory networks is essential for identifying novel cancer biomarkers.
  • Targeting these miRNA/AKT3 interactions holds promise for developing more effective cancer therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K